#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thromboangiitis obliterans Neuroendocrine carcinoma of the skin Pancreatic carcinoma Ewing's sarcoma metastatic Stiff person syndrome Infective uveitis Von Hippel-Lindau disease Aplastic anaemia Idiopathic intracranial hypertension Non-Hodgkin's lymphoma refractory Congenital hypotransferrinaemia Lymphangiosarcoma X-linked lymphoproliferative syndrome Myxofibrosarcoma Breast cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Trials in Disease Breast angiosarcoma – Life with Disease Hereditary motor and sensory neuropathy – Treatment Medulloblastoma recurrent – Basic Information Angiosarcoma non-metastatic Mucopolysaccharidosis III – Trials in Disease Pemphigus Systemic sclerosis pulmonary – Diagnostics Glycogen storage disease type II – Trials in Disease Biotinidase deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    M1P Dipotassium Salt Atorvastatin SELTOREXANT SOFTISAN 378 Abc-24F-116 Teplizumab Mps-200 Maribavir Mva-209-Fsp-B1 Alks 2680 Crofelemer Zanubrutinib Sodium Sulfate Anhydrous Mometasone Furoate Motixafortide Fremanezumab CHLOROQUINE PHOSPHATE Magrolimab GSKVX000000034797 Nelivaptan More therapies…

    Learn about Your Condition

    Myocarditis post infection Vasospasm Hypoalbuminaemia Dermatomyositis Lichen planus Ear discomfort Polymyalgia rheumatica Atrial fibrillation Agitation Erythema Rabies Heparin resistance Renal cell carcinoma stage IV Lymphatic malformation Thymoma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of apremilast‑induced headache and migraine in women with migraine without aura

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Migraine without aura
    Investigated Drugs:
    • Apremilast
    Denmark

  • Durvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    France

  • Micronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility
    • Infertility female
    Investigated Drugs:
    • Progesterone, Micronised
    The Netherlands

  • Dalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Investigated Drugs:
    • Ampicillin
    • Cefaclor
    • Cefalexin
    Germany

  • Safety and Tolerability of Inhaled KB707 with or without Docetaxel in Patients with Advanced Lung Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Docetaxel
    France Spain

  • Safety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Belgium France Germany Portugal Spain
Previous Page
1 … 685 686 687 688 689 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!